Table 1.
Laboratory data on admission
| Complete blood cell count | |
|---|---|
| White blood cell (/µL) | 4,100 |
| Neutrophil (%) | 66.5 |
| Eosinophil (%) | 1.5 |
| Lymphocyte (%) | 13.5 |
| Hemoglobin (g/dL) | 9.2 |
| Platelet (×104/µL) | 3.6 |
| Coagulation test | |
|---|---|
| APTT (s) | 30.6 |
| PT (%) | 79.8 |
| PT-INR | 1.11 |
| Fibrinogen (mg/dL) | 337.8 |
| FDP (µg/mL) | 37.3 |
| D-dimer (µg/mL) | 25 |
| Blood chemistry | |
|---|---|
| Albumin (g/dL) | 2.8 |
| Total bilirubin (mg/dL) | 1.5 |
| AST (IU/L) | 13 |
| ALT (IU/L) | 10 |
| LDH (IU/L) | 179 |
| CPK (IU/L) | 28 |
| ALP (IU/L) | 1438 |
| γGT (IU/L) | 245 |
| UN (mg/dL) | 32 |
| Creatinine (mg/dL) | 1.17 |
| Urinary acid (mg/dL) | 8.3 |
| Na (mmol/L) | 138 |
| K (mmol/L) | 4.3 |
| Cl (mmol/L) | 106 |
| IgG (mg/dL) | 893 |
| IgG4 (mg/dL) | 6 |
| IgA (mg/dL) | 169.5 |
| IgM (mg/dL) | 176.8 |
| IgE (mg/dL) | 39.4 |
| C3 (mg/dL) | 103 |
| C4 (mg/dL) | 27 |
| CH50 (U/mL) | 56 |
| C-reactive protein (mg/dL) | 7.3 |
| IL-6 (ng/L) | 21.6 |
| TNF-α (pg/mL) | 3.1 |
| VEGF (pg/mL) | 454 |
| BNP (pg/mL) | 182 |
| sIL-2R (U/mL) | 803 |
| Urinalysis | |
|---|---|
| Sediment | |
| RBC (/HPF) | 5 to 10 |
| WBC (/HPF) | 1–4 |
| Cast | None |
| Protein (g/gCre) | 0.41 |
| NAG (IU/day) | 14 |
| α1 microglobulin (mg/day) | 14 |
| β2 microglobulin (mg/day) | 50 |
APTT activated partial thromboplastin, PT prothrombin time, PT-INR prothrombin time-international normalized ratio, FDP fibrinogen degradation products, AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, CPK creatine phosphokinase, ALP alkaline phosphatase, γGTP γ-glutamyl transferase, UN urea nitrogen, CH50 hemolytic complement activity, TNF-α tumor necrosis factor-α, VEGF vascular endothelial growth factor, BNP brain natriuretic peptide, sIL-2R soluble interleukin-2 receptor, RBC red blood cell, HPF high-power field, WBC white blood cell, NAG N-acetyl-β-d-glucosaminidase